MSD has fleshed out its cardiovascular disease pipeline by licensing an oral Lp (a) inhibitor from China's Jiangsu Hengrui ...

Connor Clark & Lunn Investment Management Ltd. lowered its position in Novartis AG (NYSE:NVS – Free Report) by 95.6% in the 4th quarter, according to the company in its most recent Form 13F filing ...

Novartis said that the latest round of job losses is a result of a change in focus for its cardiovascular teams as they lower the emphasis on Entresto and devote more resources to its twice-yearly ...

Novartis Pharmaceuticals is removing hundreds of New Jersey employees from its company. The global drugmaker will lay off 427 ...

A new precision oncology paper was published in Oncotarget, Volume 16, on March 12, 2025, titled “Worldwide Innovative ...

Swiss pharmaceutical company Novartis is staying put at its Midtown office right next to Bryant Park. “We worked closely with Novartis to secure a new lease extension that addressed the firm’s current ...

Please note there are only 20 spaces available on the course. Students will then have the opportunity to complete Lab Report's if they wish to be awarded credits for the course. This can be completed ...

Rocket Lab reported earnings last week, but that's not all the news it shared. It's also planning a floating landing pad, and it has invented a flatter satellite. It also doubled one launch ...

The Trump Administration reversed course on plans to terminate the lease of a major Food and Drug Administration quality lab, Endpoints News reports. The St. Louis facility was one of about 30 FDA ...

said David Soergel, M.D., Global Head, Cardiovascular, Renal and Metabolism Development Unit, Novartis. “Building on our longstanding expertise in nephrology and recent advancements in kidney diseases ...

At Novartis, we believe in the importance of balancing professional and personal responsibilities. This belief is embodied through our inclusive parental leave policy, which supports all our people in ...

The Novartis partnership involves gaining its ... In November, Syngenta unveiled a $140 million laboratory and research facility on its Greensboro campus. The facility exemplified the company's ...